Clinical Trial: A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With Obesity

U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285902) titled 'A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With Obesity' on Dec. 03.

Brief Summary: This study is a multicenter, randomized, open-label, parallel-controlled, phase III study to compare the efficacy, safety, and tolerability of HRS9531 versus semaglutide once weekly (QW) in adult subjects with obesity

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Obesity

Intervention: DRUG: HRS9531 injection

HRS9531 injection

DRUG: Semaglutide Injection

Semaglutide Injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd....